
WHO moves to resume preventive cholera vaccination campaigns after multi-year shortfall
Read Our Expert Analysis
Create an account or login for free to unlock our expert analysis and key takeaways for this development.
By continuing, you agree to receive marketing communications and our weekly newsletter. You can opt-out at any time.
Recommended for you
Robert F. Kennedy Jr. Reorients U.S. Vaccine Strategy, Pressures Gavi
HHS Secretary Robert F. Kennedy Jr. has tied U.S. financial support to a timetable for removing the preservative thimerosal from vaccines supplied to low-resource settings, and a U.S.-backed newborn hepatitis B trial in Guinea-Bissau is now at risk as ethics and funding questions mount. Public-health bodies say the science does not support safety-driven removal, making the move politically driven and likely to fragment procurement, raise costs, and slow research and immunization programs.

Chinese Academy of Sciences pilots mosquito-delivered vaccines for bats
Researchers at the Chinese Academy of Sciences report that engineered mosquitoes and oral baits can transfer vaccine antigens to bats, producing protective antibodies against rabies and candidate Nipah antigens. The experiment suggests an operational pathway to reduce zoonotic spillover risk but raises ecological, regulatory, and scalability questions for field deployment.

China's aid push gains visibility as U.S. rewires foreign assistance
China has escalated high-profile donations — including a $137M earthquake package and a $500M WHO contribution — while U.S. foreign-aid structures have been pared back, creating diplomatic openings. This funding choreography shifts short-term influence toward Beijing even as sustainability and capacity gaps limit its ability to replace long-term U.S. global health leadership.
U.S. Aid Pause Strains Global HIV Response
The U.S. aid pause triggered a temporary data blackout while treatment numbers largely held steady; quality and prevention services fell sharply. Preliminary figures show a ~100,000 net treatment shortfall and a roughly 10 million drop in HIV tests, signaling deep service degradation despite near-term stability.